Immunization with pseudorabies virus harboring Fc domain of IgG makes a contribution to protection of mice from lethal challenge

Vaccine

Volumn 23, Issue 29, 2005, Pages 3775-3782

  Takashima, Yasuhiro ^a,b   Tsukamoto, Mikuru ^a   Ota, Haruko ^a   Matsumoto, Yasunobu ^a   Hayashi, Yoshihiro ^a   Otsuka, Haruki ^a,c  

^a UNIVERSITY OF TOKYO   (Japan)

^b GIFU UNIVERSITY   (Japan)

^c OBIHIRO UNIVERSITY OF AGRICULTURE AND VETERINARY MEDICINE   (Japan)

Author keywords

Fc; Pseudorabies virus; Vaccine

Indexed keywords

IMMUNOGLOBULIN G; INACTIVATED VIRUS VACCINE; PSEUDORABIES VACCINE;

ANIMAL MODEL; ANTIBODY PRODUCTION; ANTIBODY RESPONSE; ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; IMMUNIZATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTECTION; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROVOCATION TEST; PSEUDORABIES HERPETOVIRUS; RABIES; VIRUS VIRULENCE;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; ANTIBODIES, VIRAL; CELL LINE; DISEASE MODELS, ANIMAL; HERPESVIRUS 1, SUID; IMMUNOGLOBULIN FC FRAGMENTS; IMMUNOGLOBULIN G; MICE; MICE, INBRED BALB C; PSEUDORABIES VACCINES; SWINE; VACCINES, INACTIVATED;

EID: 18944391581     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2005.02.031     Document Type: Article

References (31)

1. T.G. Kimman Acceptability of Aujeszky's disease vaccines Dev Biol Standard 79 1992 129 136
2. T.C. Mettenleiter Pseudorabies (Aujeszky's disease) virus: state of the art Acta Vet Hung 42 2/3 1994 153 177
3. J.D. Ji, I. Tassiulas, K.H. Park-Min, A. Aydin, I. Mecklenbrauker, and A. Tarakhovsky Inhibition of interleukin 10 signaling after Fc receptor ligation and during rheumatoid arthritis J Exp Med 197 11 2003 1573 1583
4. V.C. Huber, J.M. Lynch, D.J. Bucher, J. Le, and D.W. Metzger Fc receptor-mediated phagocytosis makes a significant contribution to clearance of influenza virus infections J Immunol 166 12 2001 7381 7388
5. D. Perez-Bercoff, A. David, H. Sudry, F. Barre-Sinoussi, and G. Pancino Fcgamma receptor-mediated suppression of human immunodeficiency virus type 1 replication in primary human macrophages J Virol 77 7 2003 4081 4094
6. F. Villinger, A.E. Mayne, P. Bostik, K. Mori, P.E. Jensen, and R. Ahmed Evidence for antibody-mediated enhancement of simian immunodeficiency virus (SIV) Gag antigen processing and cross presentation in SIV-infected rhesus macaques J Virol 77 1 2003 10 24
7. M.T. Esser, D.R. Graham, L.V. Coren, C.M. Trubey, J.W. Bess Jr., and L.O. Arthor Differential incorporation of CD45, CD80 (B7-1), CD86 (B7-2), and major histocompatibility complex class I and II molecules into human immunodeficiency virus type 1 virions and microvesicles: implications for viral pathogenesis and immune regulation J Virol 75 13 2001 6173 6182
8. T. Yoneto, S. Waki, T. Takai, Yi. Tagawa, Y. Iwakura, and J. Mizuguchi Yoshimoto TA. critical role of Fc receptor-mediated antibody-dependent phagocytosis in the host resistance to blood-stage Plasmodium berghei XAT infection J Immunol 166 10 2001 6236 6241
9. T. Moore, G.A. Ananaba, J. Bolier, S. Bowers, T. Belay, and F.O. Eko Fc receptor regulation of protective immunity against Chlamydia trachomatis Immunology 105 2002 213 221
10. T. Moore, C.O. Ekworomadu, F.O. Eko, L. MacMillan, K. Ramey, and G.A. Ananaba Fc receptor-mediated, antibody regulation of T cell immunity against intracellular pathogens J Infect Dis 188 4 2003 617 624
11. Y.M. Wen, D. Qu, and S.H. Zhou Antigen-antibody complex as therapeutic vaccine for viral hepatitis B Int Rev Immunol 18 3 1999 251 258
12. Z. You, X. Huang, J. Hester, H.C. Toh, and S.Y. Chen Targeting dendritic cells to enhance DNA vaccine potency Cancer Res 61 9 2001 3704 3711
13. P.F. Stabila, S.C. Wong, F.A. Kaplan, and W. Tao Cell surface expression of a human IgG Fc chimera activates macrophages through Fc receptors Nat Biotechnol 16 13 1998 1357 1360
14. J.S. Gerber, and D.M. Mosser Stimulatory and inhibitory signals originating from the macrophage Fcγ receptors Microb Infect 3 2 2001 131 139
15. C.A. Gray, and R.A. Lawrence A role for antibody and Fc receptor in the clearance of Brugia malayi microfilariae Eur J Immunol 32 4 2002 1114 1120
16. A. Hiasa, M. Watanabe, H. Okada, K. Ikenaka, T. Fujita, and T. Toshimatsu Retroviruses prepared from human DAF expressing murine packaging cells acquire resistance against human serum Int J Oncol 14 6 1999 1091 1096
17. O. Krauss, R. Hollinshead, M. Hollinshead, and G.L. Smith An investigation of incorporation of cellular antigens into vaccinia virus particles J Gen Virol 83 10 2002 2347 2359
18. K. Maeda, S. Hayashi, Y. Tanioka, Y. Matsumoto, and H. Otsuka Pseudorabies viras (PRV) is protected from complement attack by cellular factors and glycoprotein C (gC) Virus Res 84 1/2 2002 79 87
19. D. Montefiori, R.J. Ccornell, J.Y. Zhou, J.T. Zhou, V.M. Hirsh, and P.R. Johson Complement control proteins, CD46, CD55, and CD59, as common surface constituents of human and simian immunodeficiency viruses and possible targets for vaccine protection Virology 205 l 1994 82 92
20. M. Saifuddin, T. Hedayati, J.P. Atkinson, M.H. Holguin, C.J. Parker, and G.T. Spear Human immunodeficiency virus type 1 incorporates both glycosyl phosphatidylinositol-anchored CD55 and CD59 and integral membrane CD46 at levels that protect from complement-mediated destruction J Gen Virol 78 8 1997 1907 1911
21. S. Kit, M. Sheppard, and M. Kit Control of Aujeszky's disease Vet Res 118 11 1986 310
22. M. Okabe, M. Ikawa, K. Kominami, T. Nakanishi, and Y. Nishimune Green mice as a source of ubiquitous green cells FEBS Lett 407 3 1997 313 319
23. K. Maeda, K. Hirasawa, Y. Kawaguchi, M. Ono, T. Mori, and T. Gemma Expression and identification of the feline herpesvirus type1 glycoprotein B (gp143/108) Virus Res 39 1 1995 55 61
24. A.K. Cheung DNA nucleotide sequence analysis of the immediate-early gene of pseudorabies virus Nucl Acids Res 17 12 1989 4637 4646
25. C.F. Anderson, and D.M. Mosser Biasing immune responses by directing antigen to macrophage Fc gamma receptors J Immunol 168 8 2002 3697 3701
26. A.T. Bianchi, H.W. Moonen-Leusen, F.J. van Milligen, H.F. Savelkoul, R.J. Zwart, and T.G. Kimman A mouse model to study immunity against pseudorabies virus infection: significance of CD4+ and CD8+ cells in protective immunity Vaccine 16 16 1998 1550 1558
27. S. Amigorena Fcγ receptors and cross-presentation in dendritic cells J Exp Med 195 1 2002 F1 F3
28. J.F. Giguere, J.S. Paquette, S. Bounou, R. Cantin, and M.J. Tremblay New insights into the functionality of a virion-anchored host cell membrane protein: CD28 versus HIV type 1 J Immunol 169 5 2002 2762 2771
29. R. Clynes, J.S. Maizes, R. Guinamard, M. Ono, T. Takai, and J.V. Ravetch Modulation of immune complex-induced inflammation in vivo by the coordinate expression of activation and inhibitory Fc receptors J Exp Med 189 1 1999 179 185
30. T. Takai, M. Ono, M. Hikida, H. Ohmori, and J.V. Ravetch Augumented humoral and anaphylactic responses in Fc g RII-deficient mice Nature 379 6563 1996 346 349
31. T. Yuasa, S. Kudo, T. Yoshino, A. Ujike, K. Matsumura, and M. Ono Deletion of fcg receptor IIB render H-2(b) mice susceptible to collagen-induced arthritis J Exp Med 189 1 1999 187 194